A high level of PTPL1 mRNA expression in Kaposi's sarcoma, hepatocellular carcinomas, pancreatic adenocarcinomas, as well as with higher expression in T helper cells type 1 (which are resistant to apoptosis) versus T helper cells type 2 (which are sensitive to Fas ligand), also shows a correlation between tumor cell survival in the presence of PTPL1 expression (11,30–32). Here, PTPN13 is linked to pancreatic adenocarcinoma.